1-5 of 5
Maurilio Ponzoni, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Randomized Phase II Trial on Primary Chemotherapy with High-Dose Methotrexate Alone or Associated with High-Dose Cytarabine for Patients with Primary CNS Lymphoma (IELSG #20 Trial): Tolerability, Activity and Event-Free Survival Analysis

Andres JM Ferreri, MD, Michele Reni, M.D., Marco Foppoli, M.D., Maurizio Martelli, M.D., Marina Siakantaris, M.D., Maurizio Frezzato, M.D., Maria Giuseppina Cabras, M.D., Alberto Fabbri, M.D., Gaetano Corazzelli, M.D., Fiorella Ilariucci, M.D., Giuseppe Rossi, M.D., Riccardo Soffietti, M.D., Caterina Stelitano, M.D., Daniele Vallisa, M.D., Francesco Zaja, M.D., Marta Gelemur, M.D., Gian Marco Aondio, M.D., Giuseppe Avvisati, M.D., Monica Balzarotti, MD, Alba Brandes, M.D., Maria Joao Costa, MD, Henry Gomez, M.D., Attilio Guarini, M.D., Graziella Pinotti, M.D., Luigi Rigacci, M.D., Catrina Uhlmann, M.D., Maria Angelopoulou, M.D., Maria Tirindelli, M.D., Virginia Naso, M.D., Alberto Franzin, M.D., Nicoletta Anzalone, M.D., Maurilio Ponzoni, M.D., Emanuele Zucca, M.D., Federico Caligaris- Cappio, M.D., Franco Cavalli, M.D.
Journal: Blood
Blood (2008) 112 (11): 580.
https://doi.org/10.1182/blood.V112.11.580.580
Published: 2008
Journal Articles

A Six-Month Regimen of Oral Clarithromycin Is a Feasible and Active Therapy for Patients with Relapsed/Refractory Marginal Zone B-Cell Lymphoma of MALT-Type

Andres JM Ferreri, MD, Giuseppina Patrizia Dognini, M.D., Roberto Crocchiolo, M.D., Silvia Govi, M.D., Giada Licata, M.D., Maurilio Ponzoni, M.D., Antonio Giordano Resti, M.D., Letterio Salvatore Politi, M.D., Alberto Rosso, M.D., Eugenio Villa, M.D.
Journal: Blood
Blood (2008) 112 (11): 3062.
https://doi.org/10.1182/blood.V112.11.3062.3062
Published: 2008
Journal Articles

A Cumulative Series from 14 Western Countries Suggests That Rituximab Significantly Changed the Dismal Natural History of Intravascular Large B-Cell Lymphoma (IVL) .

Andres JM Ferreri, MD, Silvia Govi, M.D., Giuseppina Patrizia Dognini, M.D., Maria Bouzani, M.D., Claudia Ruth Bollinguer, M.D., Michel D’Incan, M.D., Emmanuel Delaporte, M.D., Mehdi Hamadani, M.D., Fabrice Jardin, M.D., Magdalena Martusewicz-Boros, M.D., Mauro Montanari, M.D., Arpad Szomor, M.D., Roberto Crocchiolo, M.D., Emanuele Zucca, M.D., Franco Cavalli, M.D., Maurilio Ponzoni, M.D.
Journal: Blood
Blood (2008) 112 (11): 2008.
https://doi.org/10.1182/blood.V112.11.2008.2008
Published: 2008
Journal Articles

In Vitro Activity of SYK and BCR-ABL Inhibitors in Aggressive Lymphomas.

Francesco Bertoni, MD, Andrea Rinaldi, B. Sc., Anna Sasso, Gianluca Gaidano, M.D., PhD, Emanuele Zucca, M.D., Silvia Uccella, M.D., Giancarlo Pruneri, M.D., Maurilio Ponzoni, M.D., Maria Grazia Tibiletti, B.Sc., Carlo Catapano, M.D., PhD, Franco Cavalli, M.D.
Journal: Blood
Blood (2006) 108 (11): 2520.
https://doi.org/10.1182/blood.V108.11.2520.2520
Published: 2006
Journal Articles

Modeling the Genotoxicity of Viral Vector Integration in a Tumor Prone Hematopoietic Stem Cell Transplantation Model.

Eugenio Montini, PhD, Daniela Cesana, Ms.Sci., Manfred Schmidt, Ph.D., Francesca Sanvito, M.D., Maurilio Ponzoni, M.D., Lucia Sergi Sergi, Ms.Sci., Fabrizio Benedicenti, Ms.Sci., Cynthia Bartholomae, Ms.Sci., Clelia Di Serio, Ph.D., Claudio Doglioni, M.D., Christof von Kalle, M.D., Luigi Naldini, M.D. Ph.D.
Journal: Blood
Blood (2006) 108 (11): 451.
https://doi.org/10.1182/blood.V108.11.451.451
Published: 2006